Medical Evidence
Effects of HemaShock® use in normal volunteers on blood pressure (Fig 1) and amount of blood displaced from the legs to central circulation (Fig 2)
The HemaShock® was kept on each subject for 20 minutes.
For study design and detailed results, including respiratory and biochemical parameters please read the entire paper.
HemaShock® in Hemorrhagic Shock Cases
Preliminary clinical validation of HemaShock® in hemorrhagic shock cases was carried out at the Eisenhower Medical Center, Rancho Mirage, CA, USA.
HemaShock® was placed on 10 patients who presented to the ED, all in critical condition due to massive blood loss. It must be noted that the device was only placed within the hospital setting, and not, as intended, by EMS personnel, i.e. a delay that potentially influences the clinical outcome.
Nevertheless:
- 8 out of 10 patients responded to HemaShock® by immediately increasing BP
- 6 of those were stabilized and able to proceed to the next level of care
- 3 patients out of the 10 treated cases, were ultimately discharged home
The Figure below briefly summarizes these results.
Medical Evidence articles
Clinical Case: HemaShock Use in Elderly Man in Circulatory Arrest
An elderly man collapsed at a restaurant. This elderly gentleman had an AICD in place that shocked him three times and each time he did
Clinical Case: HemaShock Use in an Elderly Woman in Severe Hemorrhagic Shock
An elderly woman was brought into the ED after being found down in bed by a relative. She had been complaining of stomach pain for
HemaShock in Cardiac Arrest Cases
Preliminary clinical validation of the HemaShock® in cardiac arrest cases was carried out at the Eisenhower medical center, Rancho Mirage, CA, USA. HemaShock® was applied to 17 patients,